U.S. Markets close in 5 hrs 17 mins

iCAD, Inc. (ICAD)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.55-0.24 (-5.01%)
As of 10:34AM EDT. Market open.
People also watch
IRIXICCCINODIDSYDRAD
Interactive chart
Previous Close4.79
Open4.70
Bid4.55 x 400
Ask4.68 x 200
Day's Range4.55 - 4.70
52 Week Range2.82 - 6.49
Volume500
Avg. Volume50,985
Market Cap74.51M
Beta1.32
PE Ratio (TTM)-9.08
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research15 days ago

    ICAD: Q1: Strong Detection Offsets Weakness in NMSC Revenue

    Relative to our estimates, Q1 Detection revenue was about 20% better which more than offset a 7% miss to our Therapy number – the net result was a 9% beat to our total revenue estimate.  Detection was the clear highlight with revenue up 14% yoy – but excluding MRI revenues (i.e. Strength in Detection was attributed to 3D tomo sales in Europe – management noted 7 or 8 systems were sold in Q1 – as well as from “several very large (2D) tenders.”  Management mentioned that Q1 set a new record in terms of international CAD orders.  We note that since ordering patterns can be somewhat lumpy, we have not carried that level of revenue through to our Q2 number – but we also note that management indicated interest in 3D tomo in Europe continues to solidify and, as such, we think it is reasonable to expect that product will to continue to gain traction.

  • Thomson Reuters StreetEvents18 days ago

    Edited Transcript of ICAD earnings conference call or presentation 2-May-17 8:30pm GMT

    Q1 2017 ICAD Inc Earnings Call

  • Zacks Small Cap Research18 days ago

    ICAD: U.S. Tomo Launched, Should Be 2017 Catalyst

    Strength in Detection was attributed to 3D tomo sales in Europe – management noted 7 or 8 systems were sold in Q1 – as well as from “several very large (2D) tenders.”  Management mentioned that Q1 set a new record in terms of international CAD orders.  We note that since ordering patterns can be somewhat lumpy, we have not carried that level of revenue through to our Q2 number – but we also note that management indicated interest in 3D tomo in Europe continues to solidify and, as such, we think it is reasonable to expect that product will to continue to gain traction.